Atlas Trials

Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose

Clinical trial NCT01465243 · COMPLETED

Trial details

NCT number
NCT01465243
Sponsor
Betta Pharmaceuticals Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2011-09-01
Primary completion
2013-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.